This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Source-linked NID1 Western blot protocol options, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-NID1 WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, source-linked protocol options, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~136.4 kDa | |
| Observed band | ~150 kDa | |
| Gel | 8% (catalog A05621) | |
| Negative control | Suggested KO / knockdown lysate |
| PTM | Glycosylated + Cleaved | |
| Caveat | Modification-state controls | |
| Gene-set association | MSigDB C7 membership | |
| Isoform | 2 isoform(s) |
The A05621 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.
| Sample / lysate | human HepG2, human THP-1, human 293T, mouse heart (catalog A05621) |
| Gel % | 8% (catalog A05621) |
| Load | 30 ug; reducing conditions (catalog A05621) |
| Transfer | a nitrocellulose membrane at 150 mA for 50-90 minutes (catalog A05621) |
| Membrane | nitrocellulose membrane (catalog A05621) |
| Blocking | 5% non-fat milk/TBS for 1.5 hour at RT (catalog A05621) |
| Primary antibody | A05621 · 0.5 μg/mL (catalog A05621) |
| Primary incubation | overnight at 4°C (catalog A05621) |
| Secondary antibody | goat anti-rabbit IgG-HRP, 1:5000 (catalog A05621) |
| Secondary incubation | 1.5 hour at RT (catalog A05621) |
| Wash | TBS-0.1%Tween 3 times with 5 minutes each (catalog A05621) |
| Detection | ECL (catalog A05621) |
NID1 is predicted at 136.4 kDa and observed near 150 kDa in antibody QC blots; the cause of the difference is not established.
| Band near 150 kDa | Empirical NID1 band in antibody QC blots; its difference from the 136.4 kDa predicted mass has no established cause. |
| Little or no band in whole-cell lysate | NID1 is secreted into the extracellular matrix. |
| Band below the precursor | Signal-peptide cleavage could produce a smaller mature protein; confirm its identity. |
| Multiple bands | Isoforms 1 and 2 are annotated, but distinct migration has not been demonstrated. |
| UniProt predicted mass | 136.4 kDa is the precursor sequence mass; the empirical band is near 150 kDa. |
| O-linked GalNAc at Thr922 | May affect migration, but a visible shift is not established. |
| O-linked GalNAc at Thr935 | May affect migration, but a visible shift is not established. |
| Signal peptide at residues 1–28 | Cleavage makes the mature protein smaller than the precursor; its apparent mass is not supplied. |
| Isoforms 1 and 2 | Sequence differences may affect size, but their relative masses and migration are not supplied. |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | NID1 is secreted into the extracellular matrix. | Check conditioned medium or an extracellular matrix fraction alongside a positive control. |
| Band higher than expected | The observed band near 150 kDa exceeds the 136.4 kDa prediction; the cause is unestablished. | Confirm identity with a positive control and NID1 depletion. |
| Band lower than expected | Signal-peptide cleavage can lower mass relative to the precursor. | Compare with a positive control and verify band identity before assigning processing. |
| Multiple bands | Isoforms 1 and 2 are annotated, but their migration is unknown. | Check isoform expression and use NID1 depletion to identify specific bands. |
| Weak or no signal | Secreted NID1 may be scarce in the sampled cell fraction. | Test conditioned medium or extracellular matrix material with a positive control. |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| No high/medium HPA tissues identified in the supplied evidence. | ||||
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| No lower-expression tissue rows available in the supplied evidence. | ||||
Deeper troubleshooting and optimisation questions for NID1, answered from its protein features.
Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.
Three the supplier anti-NID1 antibodies have WB images: A05621 in human cell lines and mouse heart, M05621 in human fetal heart, and A05621-1 in K562 cells with peptide blocking. These captions document specific samples, not broad validation.
Which to pick: Choose A05621 for its documented human and mouse WB samples and detailed conditions. M05621 shows human fetal heart lysate. A05621-1 lists human, mouse, and rat reactivity, but its WB image uses K562 cells; rat WB performance is not shown.